Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases
详细信息 查看全文
- 作者：Zsuzsanna H McMahan (1)
Clifton O Bingham III (1)
1. Department of Medicine ; Division of Rheumatology ; Johns Hopkins University ; 5200 Eastern Avenue ; Mason F Lord Center Tower ; Room 4100 ; Baltimore ; MD ; 21224 ; USA - 刊名：Arthritis Research & Therapy
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：16
- 期：6
- 全文大小：433 KB
- 参考文献：1. Curtis, JR, Arora, T, Narongroeknawin, P, Taylor, A, Bingham, CO, Cush, J, Saag, KG, Safford, M, Delzell, E (2010) The delivery of evidence-based preventive care for older Americans with arthritis. Arthritis Res Ther 12: pp. R144 CrossRef
2. Duchet-Niedziolka, P, Launay, O, Coutsinos, Z, Ajana, F, Arlet, P, Barrou, B, Beytout, J, Bouchaud, O, Brouqui, P, Buzyn, A, Chidiac, C, Couderc, LJ, Debord, T, Dellamonica, P, Dhote, R, Duboust, A, Durrbach, A, Fain, O, Fior, R, Godeau, B, Goujard, C, Hachulla, E, Marchou, B, Mariette, X, May, T, Meyer, O, Milpied, N, Morlat, P, Pouchot, J, Tattevin, P (2009) Vaccination in adults with auto-immune disease and/or drug related immune deficiency: results of the GEVACCIM Delphi survey. Vaccine 27: pp. 1523-1529 CrossRef
3. Patel, NC, Hertel, PM, Estes, MK, Morena, M, Petru, AM, Noroski, LM, Revell, PA, Hanson, IC, Paul, ME, Rosenblatt, HM, Abramson, SL (2010) Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med 362: pp. 314-319 CrossRef
4. Harpaz, R, Ortega-Sanchez, IR, Seward, JF (2008) Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 57: pp. 1-30
5. Zhang, J, Xie, F, Delzell, E, Chen, L, Winthrop, KL, Lewis, JD, Saag, KG, Baddley, JW, Curtis, JR (2012) Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA 308: pp. 43-49
6. Winthrop, KL, Baddley, JW, Chen, L, Liu, L, Grijalva, CG, Delzell, E, Beukelman, T, Patkar, NM, Xie, F, Saag, KG, Herrinton, LJ, Solomon, DH, Lewis, JD, Curtis, JR (2013) Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA 309: pp. 887-895 CrossRef
7. Pileggi, GS, Souza, CB, Ferriani, VP (2010) Safety and immunogenicity of varicella vaccine in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids. Arthritis Care Res (Hoboken) 62: pp. 1034-1039 CrossRef
8. Borte, S, Liebert, UG, Borte, M, Sack, U (2009) Efficacy of measles, mumps and rubella revaccination in children with juvenile idiopathic arthritis treated with methotrexate and etanercept. Rheumatology (Oxford) 48: pp. 144-148 CrossRef
9. Scheinberg, M, Guedes-Barbosa, LS, Mangueira, C, Rosseto, EA, Mota, L, Oliveira, AC, Lima, RA (2010) Yellow fever revaccination during infliximab therapy. Arthritis Care Res (Hoboken) 62: pp. 896-898 CrossRef
10. Shearer, WT, Fleisher, TA, Buckley, RH, Ballas, Z, Ballow, M, Blaese, RM, Bonilla, FA, Conley, ME, Cunningham-Rundles, C, Filipovich, AH, Fuleihan, R, Gelfand, EW, Hernandez-Trujillo, V, Holland, SM, Hong, R, Lederman, HM, Malech, HL, Miles, S, Notarangelo, LD, Ochs, HD, Orange, JS, Puck, JM, Routes, JM, Stiehm, ER, Sullivan, K, Torgerson, T, Winkelstein, J (2014) Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol 133: pp. 961-966 CrossRef
11. Carr, S, Allison, KJ, Velde, LA, Zhang, K, English, EY, Iverson, A, Daw, NC, Howard, SC, Navid, F, Rodriguez-Galindo, C, Yang, J, Adderson, EE, McCullers, JA, Flynn, PM (2011) Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis 204: pp. 1475-1482 CrossRef
12. Bridges, CB, Woods, L, Coyne-Beasley, T (2013) Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older - United States, 2013. MMWR Surveill Summ 62: pp. 9-19
13. Jackson, LA, Gurtman, A, Cleeff, M, Frenck, RW, Treanor, J, Jansen, KU, Scott, DA, Emini, EA, Gruber, WC, Schmoele-Thoma, B (2013) Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine 31: pp. 3594-3602 CrossRef
14. Elkayam, O, Paran, D, Caspi, D, Litinsky, I, Yaron, M, Charboneau, D, Rubins, JB (2002) Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 34: pp. 147-153 CrossRef
15. Dixon, WG, Abrahamowicz, M, Beauchamp, ME, Ray, DW, Bernatsky, S, Suissa, S, Sylvestre, MP (2012) Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case鈥揷ontrol analysis. Ann Rheum Dis 71: pp. 1128-1133 CrossRef
16. Greenberg, JD, Reed, G, Kremer, JM, Tindall, E, Kavanaugh, A, Zheng, C, Bishai, W, Hochberg, MC (2010) Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Ann Rheum Dis 69: pp. 380-386 CrossRef
17. Kapetanovic, MC, Saxne, T, Nilsson, JA, Geborek, P (2007) Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 46: pp. 608-611 CrossRef
18. Bingham, CO, Looney, RJ, Deodhar, A, Halsey, N, Greenwald, M, Codding, C, Trzaskoma, B, Martin, F, Agarwal, S, Kelman, A (2010) Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 62: pp. 64-74 CrossRef
19. Assen, S, Holvast, A, Benne, CA, Posthumus, MD, Leeuwen, MA, Voskuyl, AE, Blom, M, Risselada, AP, Haan, A, Westra, J, Kallenberg, CG, Bijl, M (2010) Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 62: pp. 75-81 CrossRef
20. Kapetanovic, MC, Roseman, C, Jonsson, G, Truedsson, L (2011) Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs. Clin Rheumatol 30: pp. 1555-1561 CrossRef
21. Kapetanovic, MC, Roseman, C, Jonsson, G, Truedsson, L, Saxne, T, Geborek, P (2011) Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors. Arthritis Rheum 63: pp. 3723-3732 CrossRef
22. Bingham CO 3rd, Rizzo W, Kivitz A, Hassanali A, Upmanyu R, Klearman M: Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). / Ann Rheum Dis 2014. doi: 10.1136/annrheumdis-2013-204427. [Epub ahead of print]
23. Heijstek, MW, Kamphuis, S, Armbrust, W, Swart, J, Gorter, S, Vries, LD, Smits, GP, Gageldonk, PG, Berbers, GA, Wulffraat, NM (2013) Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA 309: pp. 2449-2456 CrossRef
24. Kollaritsch, H, Que, JU, Kunz, C, Wiedermann, G, Herzog, C, Cryz, SJ (1997) Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine. J Infect Dis 175: pp. 871-875 CrossRef
25. Gabay, C, Bel, M, Combescure, C, Ribi, C, Meier, S, Posfay-Barbe, K, Grillet, S, Seebach, JD, Kaiser, L, Wunderli, W, Guerne, PA, Siegrist, CA (2011) Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum 63: pp. 1486-1496 CrossRef
26. Mok, CC, Ho, LY, Fong, LS, To, CH (2013) Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case鈥揷ontrol study. Ann Rheum Dis 72: pp. 659-664 CrossRef
27. Trollmo, C, Gudmundsson, S, Feltelius, N, Rogberg, S, Smedegard, G, Klareskog, L (2007) Sulphasalazine inhibits human antigen-specific immune responses in vivo. Ann Rheum Dis 66: pp. 481-485 CrossRef
28. Kanerud, L, Engstrom, GN, Tarkowski, A (1995) Evidence for differential effects of sulphasalazine on systemic and mucosal immunity in rheumatoid arthritis. Ann Rheum Dis 54: pp. 256-262 CrossRef
29. Zonneveld-Huijssoon, E, Ronaghy, A, Rossum, MA, Rijkers, GT, Klis, FR, Sanders, EA, Vermeer-De Bondt, PE, Hoes, AW, Net, JJ, Engels, C, Kuis, W, Prakken, BJ, Tol, MJ, Wulffraat, NM (2007) Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. Arthritis Rheum 56: pp. 639-646 CrossRef
30. Ribeiro, AC, Guedes, LK, Moraes, JC, Saad, CG, Aikawa, NE, Calich, AL, Franca, IL, Carvalho, JF, Sampaio-Barros, PD, Goncalves, CR, Borba, EF, Timenetsky Mdo, C, Precioso, AR, Duarte, A, Bonfa, E, Laurindo, IM (2011) Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice. Ann Rheum Dis 70: pp. 2144-2147 CrossRef
31. Holvast, A, Huckriede, A, Wilschut, J, Horst, G, Vries, JJ, Benne, CA, Kallenberg, CG, Bijl, M (2006) Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease. Ann Rheum Dis 65: pp. 913-918 CrossRef
32. Keshtkar-Jahromi, M, Argani, H, Rahnavardi, M, Mirchi, E, Atabak, S, Tara, SA, Gachkar, L, Noori-Froothghe, A, Mokhtari-Azad, T (2008) Antibody response to influenza immunization in kidney transplant recipients receiving either azathioprine or mycophenolate: a controlled trial. Am J Nephrol 28: pp. 654-660 CrossRef
33. Holvast, A, Stegeman, CA, Benne, CA, Huckriede, A, Wilschut, JC, Palache, AM, Kallenberg, CG, Bijl, M (2009) Wegener鈥檚 granulomatosis patients show an adequate antibody response to influenza vaccination. Ann Rheum Dis 68: pp. 873-878 CrossRef
34. Sanchez-Fructuoso, AI, Prats, D, Naranjo, P, Fernandez-Perez, C, Gonzalez, MJ, Mariano, A, Gonzalez, J, Figueredo, MA, Martin, JM, Paniagua, V, Fereres, J, Gomez de la Concha, E, Barrientos, A (2000) Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 69: pp. 436-439 CrossRef
35. Struijk, GH, Minnee, RC, Koch, SD, Zwinderman, AH, van Donselaar-van der Pant, KA, Idu, MM, ten Berge, IJ, Bemelman, FJ (2010) Maintenance immunosuppressive therapy with everolimus preserves humoral immune responses. Kidney Int 78: pp. 934-940 CrossRef
36. Mercado, U, Acosta, H, Diaz-Molina, R (2009) Antibody response to pneumococcal polysaccharide vaccine in systemic sclerosis. J Rheumatol 36: pp. 1549-1550 CrossRef
37. Palestine, AG, Roberge, F, Charous, BL, Lane, HC, Fauci, AS, Nussenblatt, RB (1985) The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans. J Clin Immunol 5: pp. 115-121 CrossRef
38. Versluis, DJ, Beyer, WE, Masurel, N, Wenting, GJ, Weimar, W (1986) Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 42: pp. 376-379 CrossRef
39. Kapetanovic, MC, Saxne, T, Sjoholm, A, Truedsson, L, Jonsson, G, Geborek, P (2006) Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 45: pp. 106-111 CrossRef
40. Ferreira, I, Isenberg, D (2014) Vaccines and biologics. Ann Rheum Dis 73: pp. 1446-1454 CrossRef
41. Hua, C, Barnetche, T, Combe, B, Morel, J (2014) Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 66: pp. 1016-1026 CrossRef
42. Kapetanovic, MC, Kristensen, LE, Saxne, T, Aktas, T, Morner, A, Geborek, P (2014) Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis. Arthritis Res Ther 16: pp. R2 CrossRef
43. Moreland, LW, Bucy, RP, Weinblatt, ME, Mohler, KM, Spencer-Green, GT, Chatham, WW (2002) Immune function in patients with rheumatoid arthritis treated with etanercept. Clin Immunol 103: pp. 13-21 CrossRef
44. Tay, L, Leon, F, Vratsanos, G, Raymond, R, Corbo, M (2007) Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects. Arthritis Res Ther 9: pp. R38 CrossRef
45. Schiff, M, Kaell, A, Tay, L, Vratsanos, G, Baart, K (2007) Pneumococcal vaccine in rheumatoid arthritis patients with an inadequate response to anti-TNF Therapy treated with abatacept in the ARRIVE Trial. Ann Rheum Dis 66: pp. 437
46. Abrams, JR, Lebwohl, MG, Guzzo, CA, Jegasothy, BV, Goldfarb, MT, Goffe, BS, Menter, A, Lowe, NJ, Krueger, G, Brown, MJ, Weiner, RS, Birkhofer, MJ, Warner, GL, Berry, KK, Linsley, PS, Krueger, JG, Ochs, HD, Kelley, SL, Kang, S (1999) CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 103: pp. 1243-1252 CrossRef
47. Alten, R, Bingham, CO, Cohen, S, Calabrese, L, Curtis, JR, Blick, A, Fay, J, Kelly, S, Luo, A, Wong, D, Genovese, MA (2013) Antibody response to pneumococcal and influenza vaccineation in patients with RA receiving subcutaneous abatacept. Ann Rheum Dis 72: pp. 579 CrossRef
48. Oren, S, Mandelboim, M, Braun-Moscovici, Y, Paran, D, Ablin, J, Litinsky, I, Comaneshter, D, Levartovsky, D, Mendelson, E, Azar, R, Wigler, I, Balbir-Gurman, A, Caspi, D, Elkayam, O (2008) Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response. Ann Rheum Dis 67: pp. 937-941 CrossRef
49. Arad, U, Tzadok, S, Amir, S, Mandelboim, M, Mendelson, E, Wigler, I, Sarbagil-Maman, H, Paran, D, Caspi, D, Elkayam, O (2011) The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab. Vaccine 29: pp. 1643-1648 CrossRef
50. Chatham, WW, Wallace, DJ, Stohl, W, Latinis, KM, Manzi, S, McCune, WJ, Tegzova, D, McKay, JD, Avila-Armengol, HE, Utset, TO, Zhong, ZJ, Hough, DR, Freimuth, WW, Migone, TS (2012) Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial. J Rheumatol 39: pp. 1632-1640 CrossRef
51. Mori, S, Ueki, Y, Hirakata, N, Oribe, M, Hidaka, T, Oishi, K (2012) Impact of tocilizumab therapy on antibody response to influenza vaccine in patients with rheumatoid arthritis. Ann Rheum Dis 71: pp. 2006-2010 CrossRef
52. Bingham CO 3rd, Rizzo W, Kivitz A, Hassanali A, Upmanyu R, Klearman M: Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). / Ann Rheum Dis 2014. doi: 10.1136/annrheumdis-2013-204427.
53. Brodmerkel, C, Wadman, E, Langley, RG, Papp, KA, Bourcier, M, Poulin, Y, Ho, V, Guenther, L, Kunynetz, R, Nigen, S, Vender, R, Wasel, N, Hsu, MC, Szapary, P (2013) Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use. J Drugs Dermatol 12: pp. 1122-1129
54. Winthrop, K, Racewicz, A, Lee, E, Wilkinson, B, Zwillich, S, Soma, K, Rottinghaus, S, Kawabata, T, Riese, R, Wood, S, Bradley, J, Bingham, CO (2013) Evaluation of influenza and pneumococcal vaccine responses in patients with rheumatoid arthritis receiving tofacitinib. Arthritis Rheum 65: pp. Abstract 1284
55. Assen, S, Agmon-Levin, N, Elkayam, O, Cervera, R, Doran, MF, Dougados, M, Emery, P, Geborek, P, Ioannidis, JP, Jayne, DR, Kallenberg, CG, Muller-Ladner, U, Shoenfeld, Y, Stojanovich, L, Valesini, G, Wulffraat, NM, Bijl, M (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70: pp. 414-422 CrossRef - 刊物主题：Rheumatology; Orthopedics;
- 出版者：BioMed Central
- ISSN：1478-6354
文摘
Vaccinations are administered to patients to induce a protective immune response, resulting in immunological memory. Preventing infection through the use of vaccines is particularly important in immunocompromised and immunosuppressed individuals given their increased frequency and severity of infections relative to healthy individuals. Recent surveys show that the vaccination rate is still alarmingly low in patients with rheumatic disease. In this review we briefly discuss the different types of vaccines and then critically examine evidence related to vaccination efficacy in patients with autoimmune disease and the effects of immunomodulatory therapy, with an aim to provide guidance and optimize the administration of vaccines in such individuals.